Is topical monotherapy effective for localized pyoderma gangrenosum?

Archives of Dermatology

Volumn 147, Issue 1, 2011, Pages 101-103

  Le Cleach, Laurence ^a   Moguelet, Philippe ^b   Perrin, Pascal ^a   Chosidow, Olivier ^c  

^a CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^b HÔPITAL TENON   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; HYDROCORTISONE; INFLIXIMAB; PLACEBO; TACROLIMUS; TRIAMCINOLONE ACETONIDE;

ARTICLE; BURNING SENSATION; COLONOSCOPY; CONTROLLED CLINICAL TRIAL (TOPIC); DEPIGMENTATION; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRANULATION TISSUE; HISTOPATHOLOGY; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN ATROPHY; SKIN BIOPSY; SKIN NODULE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PYODERMA GANGRENOSUM; TACROLIMUS;

EID: 78751520252     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.393     Document Type: Article

References (22)

1. Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006;55(4):505-509.
2. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53(2):273-283. (Pubitemid 40979585)
3. Marzano AV, Trevisan V, Lazzari R, Crosti C. Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum. J Dermatolog Treat. 2010;21(3):140-143.
4. Kontos AP, Kerr HA, Fivenson DP, Remishofsky C, Jacobsen G. An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum. Int J Dermatol. 2006;45(11):1383-1385. (Pubitemid 44688050)
5. Deckers-Kocken JM, Pasmans SG. Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum. Arch Dis Child. 2005;90(5):531.
6. Khurrum Baig M, Marquez H, Nogueras JJ, Weiss EG, Wexner SD. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases. Colorectal Dis. 2004;6(4):250-253. (Pubitemid 38960852)
7. Vidal D, Alomar A. Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus. Br J Dermatol. 2004;150(2):387-388. (Pubitemid 38352495)
8. Reich K, Vente C, Neumann C. Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol. 1998;139(4):755-757.
9. Lyon CC, Smith AJ, Griffiths CE, Beck MH. Peristomal dermatoses: a novel indication for topical steroid lotions. J Am Acad Dermatol. 2000;43(4):679-682.
10. Nybaek H, Olsen AG, Karlsmark T, Jemec GB. Topical therapy for peristomal pyoderma gangrenosum. J Cutan Med Surg. 2004;8(4):220-223. (Pubitemid 41223720)
11. Peachey RD. Proceedings: Pyoderma gangrenosum of scalp. Br J Dermatol. 1974;90(1):106-108.
12. Ko CB, Walton S, Wyatt EH. Pyoderma gangrenosum: associations revisited. Int J Dermatol. 1992;31(8):574-577.
13. Ravi MD, Sanju N. Pyoderma gangrenosum. Indian Pediatr. 2000;37(11):1277.
14. Rosina P, Cunego S, Franz CZ, D'Onghia FS, Chieregato G. Pathergic pyoderma gangrenosum in a venous ulcer. Int J Dermatol. 2002;41(3):166-167. (Pubitemid 34601111)
15. Sakai H, Otsubo S, Iizuka H. Peristomal pyoderma gangrenosum associated with rectal adenocarcinoma. J Dermatol. 2006;33(1):68-70.
16. Sanz-Muñoz C, Martínez-Morán C, Miranda-Romero A. Pyoderma gangrenosum following cesarean delivery [in Spanish]. Actas Dermosifiliogr. 2008;99(6):477-480.
17. Mehta AJ, Charman CR. Pyoderma gangrenosum in association with autoimmune neutropenia of infancy. Pediatr Dermatol. 2008;25(6):620-622.
18. Lyon CC, Stapleton M, Smith AJ, Mendelsohn S, Beck MH, Griffiths CE. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat. 2001;12(1):13-17.
19. Albrecht J, Werth VP, Bigby M. The role of case reports in evidence-based practice, with suggestions for improving their reporting. J Am Acad Dermatol. 2009;60(3):412-418.
20. Ghislain PD, De Decker I, Lachapelle JM. Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. Br J Dermatol. 2004;150(5):1052-1053.
21. Pitarch G, Torrijos A, Mahiques L, Sánchez-Carazo JL, Fortea JM. Systemic absorption of topical tacrolimus in pyoderma gangrenosum. Acta Derm Venereol. 2006;86(1):64-65.
22. Petering H, Kiehl P, Breuer C, Kapp A, Werfel T. Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506) [in German]. Hautarzt. 2001;52(1):47-50.